Home > Healthcare > Medical Devices > Medical Supplies > Latin America Hypodermic Syringes & Needles Market

Latin America Hypodermic Syringes & Needles Market Trends

Report ID: GMI5545
Published Date: Apr 2023
Report Format: PDF

Download Free Sample

Latin America Hypodermic Syringes & Needles Market Trends

The rising incidence of injuries and infections caused by needles is likely to limit market development. Numerous blood-borne illnesses, including the human immunodeficiency virus (HIV) and hepatitis B (HBV), among others, are caused by a variety of needlestick injuries. As a result, the use of hypodermic needles may result in injuries and infections. However, healthcare professionals are increasingly turning to disposable needles and syringes, which greatly minimizes the risk of disease transmission.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Latin american market for hypodermic syringes & needles was worth more than USD 375 million in 2022 and is set to grow at over 3% CAGR through 2032 owing to the rising prevalence of chronic diseases.

Disposable segment is projected to amass more than USD 506 million by 2032 due to its growing preference for convenience and safety benefits.

Brazil hypodermic syringes & needles market is estimated to generate more than USD 179 million in revenue by 2032, owing to the growing product usage by a rising number of diabetes patients across the region.

B. Braun Melsungen AG, Becton Dickinson, & Company, Cardinal Health, Inc., Terumo Corporation, Nipro Corporation, and Medline Industries, Inc. are some of the top companies in the ndustry.